Bioidentical hormones market

Bioidentical hormones market size was valued at USD 300.78 million in 2018 and is projected to reach to USD XX million by 2026 at a CAGR of XX %.

This is a comprehensive global report focused on the current and future prospects of the bioidentical hormones market. This report is a consolidation of primary and secondary research, which provides market size, share, dynamics, and forecast for various segments and sub-segments considering the macro and microenvironmental factors. An in-depth analysis of past trends, future trends, demographics, and technological advancements for the bioidentical hormones market has been done in order to calculate the growth rates for each segment and sub-segments.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis

Bioidentical hormones are hormones that are chemically identical as those that the body produces. These hormones are used by women in Hormone Replacement Therapy (HRT) to ease the menopause symptoms such as hot flashes, reduced sex drive, vaginal dryness, night sweats, weight gain, fatigue, and mood change.

Rising screening tests for growth hormone deficiency analysis is majorly expected to drive the market growth.

Improved screening for growth hormone deficiency using logical analysis data, worldwide rising female geriatric population, and growing awareness about technology related to bioidentical hormones therapy are expected to fuel the demand for bioidentical hormones in near future.

The presence of alternative treatments for HRT is anticipated to restrain the market growth in over the forecast period.

Alternatives to HRT such as tibolone, antidepressants, clonidine, and herbal remedies can affect the adoption of HRT treatments; hence, this is anticipated to hinder the market growth in the near future.

The estrogen segment is anticipated to dominate the market during the forecast period.

The estrogen segment is expected to hold a major chunk of the market over the forecast period due to abundant source of plant estrogens coupled with rising demand for estrogen hormones such as estrone, estradiol, and estriol during HRT.

The tablet & capsule segment spearheaded the market.

The tablet and capsule segment is expected to lead the market over the forecast period due to rising preference from patients towards convenient dosage form and ease of administration.

North America is expected to hold major market share during the forecast period.

North America is expected to hold substantial market share over next ten years owing to a surge in the number of HRTs, higher spending on healthcare, rapid uptake of bioidentical hormone products in the U.S., and the presence of major market players in the region.

Key Highlights:

• Bioidentical hormones market size analysis and forecast

• Comprehensive study and analysis of market drivers, restraints, and opportunities influencing the growth of the bioidentical hormones market

• Bioidentical hormones market segmentation on the basis of type, product type, end-use, and geography (regional)

• Bioidentical hormones market strategic analysis with respect to individual growth trends, future prospects along with a contribution of various sub-market stakeholders have been considered under the scope of the study

• Bioidentical hormones market analysis and forecast for five major regions such as North America, Europe, Asia Pacific, Latin America, and MEA.

• Profiling of key industry players, their strategic perspective, market positioning and analysis of core competencies

• Competitive landscape of the key players operating in the bioidentical hormones market including competitive developments, investments, and strategic expansion

Years that have been considered for the study are as follows:

• Base Year – 2018

• Estimated Year – 2019

• Forecast Period – 2019 to 2026

For company profiles, 2018 has been considered as the base year. In cases, wherein information was unavailable for the base year, the years prior to it have been considered.

Research Methodology:

The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply side were considered while conducting interviews to get an unbiased idea of the market. This exercise was done at a country level to get a fair idea of the market in countries considered for this study. Later this country-specific data was accumulated to come up with regional numbers and then arrive at the global market value for bioidentical hormones market.

Some of the key players of the bioidentical hormones market include:

• BioTE Medical

• NutraMarks, Inc.

• SottoPelle

• Advantage Pharmaceuticals, Inc.

• Bravado Labs

• Full Life Wellness Center

• Neuva Aesthetics

• Defy Medical

• Biostation

• United Pharmacy, LLC

Key Target Audience:

• Healthcare companies

• Corporate healthcare entities

• Government agencies

• Market research and consulting firms

• Venture capitalists

• Medical Students

Scope of the Bioidentical Hormones Market Report:

The research report segments the bioidentical hormones market based on type, product type, end-use, and geography.

Bioidentical Hormones Market, By Type

• Estrogen

• Progesterone

• Testosterone

• Other

Bioidentical Hormones Market, By Product Type

• Tablet & Capsule

• Cream & Gel

• Patch & Implant

• Injectable

• Other

Bioidentical Hormones Market, By End-use

• Hospital & Clinic

• Academic & Research

• Other

Bioidentical Hormones Market, By Geography

• North America

• U.S.

• Canada

• Europe

Fore More Information Visit https://www.maximizemarketresearch.com/market-report/bioidentical-hormones-market/1854/is Report Is Submitted By : Maximize Market Research Company

Customization of the report:

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Lumawant Godage

Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: [email protected]

Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India.

Contact: +919607195908 8989132284

 

[Dhruv Bindhani]

The provided text describes the global market for bioidentical hormones, offering a snapshot of its valuation in 2018, projected growth, key drivers, restraints, and segmentation. It positions bioidentical hormones as a significant area within Hormone Replacement Therapy (HRT), particularly for menopausal symptoms.

Market Valuation and Scope:

The market for bioidentical hormones was valued at USD 300.78 million in 2018 and is projected to reach an unspecified "USD XX million" by 2026, with a CAGR of "XX %". This indicates an expected growth trajectory for the market. The report aims to be comprehensive, covering market size, share, dynamics, and forecasts across various segments, considering macro and microenvironmental factors. It also acknowledges and reflects the revenue impact of the COVID-19 pandemic on market players.

Definition and Use of Bioidentical Hormones:

Bioidentical hormones are defined as hormones that are chemically identical to those naturally produced by the human body. They are primarily used in Hormone Replacement Therapy (HRT), especially by women to alleviate symptoms associated with menopause. These symptoms include hot flashes, reduced sex drive, vaginal dryness, night sweats, weight gain, fatigue, and mood changes.

Market Drivers:

Several factors are expected to fuel the growth of the bioidentical hormones market:

• Rising screening tests for growth hormone deficiency analysis: Improved diagnostic capabilities are increasing the identification of hormonal imbalances.
• Globally rising female geriatric population: As the global population ages, more women will experience menopause and seek solutions for its symptoms.
• Growing awareness about technology related to bioidentical hormones therapy: Increased understanding and acceptance of these therapies contribute to their demand.

Market Restraints:

The primary factor anticipated to hinder market growth is the presence of alternative treatments for HRT. These alternatives include tibolone, antidepressants, clonidine, and various herbal remedies, which can affect the adoption of bioidentical HRT.

Market Segmentation Insights:

• By Type:
  • The estrogen segment is anticipated to dominate the market during the forecast period. This is attributed to the abundant plant sources of estrogen and the rising demand for estrogen hormones (estrone, estradiol, and estriol) in HRT.
• By Product Type:
  • The tablet & capsule segment spearheaded the market and is expected to lead during the forecast period. This preference is due to the convenience of this dosage form and its ease of administration for patients. Other forms include cream & gel, patch & implant, and injectable.
• By End-use: The market is segmented into Residential, Commercial, and Industrial. (Note: This might be a copy-paste error from another report, as bioidentical hormones typically relate to Hospital & Clinic, Academic & Research, and Other end-uses as per the "Scope of the Bioidentical Hormones Market Report" section later in the text).
• By Geography:
  • North America is expected to hold a major market share over the next ten years. This dominance is linked to a surge in HRT procedures, higher healthcare spending, rapid adoption of bioidentical hormone products in the U.S., and the strong presence of key market players in the region. Other regions include Europe, Asia Pacific, Latin America, and MEA.

Key Players:

The report lists several key players in the bioidentical hormones market, including BioTE Medical, NutraMarks, Inc., SottoPelle, Advantage Pharmaceuticals, Inc., and various others, indicating a competitive landscape.

Report Methodology:

The market estimation relies on triangulation of data from various sources, including paid and unpaid sources, and primary interviews with Key Opinion Leaders (KOLs) from both demand and supply sides, conducted at a country level and then aggregated for regional and global figures. The base year for the study is 2018, with an estimated year of 2019 and a forecast period from 2019 to 2026.